Paul Massoud

Ronnie Moas at Standpoint Research upgraded Alcoa Inc (NYSE: AA) from Hold to Buy Friday and set an $18 price target. Moas’ price target was for a 2016-2017 time frame with the expectation of a 30 percent upside versus a 15 percent downside risk. Moas noted that Century Aluminum Co (...

Stifel previewed earnings for Potash Corp./Saskatchewan (USA) (NYSE: POT), which will report on January 29 before the market open. Analyst Paul Massoud expected Q4 earnings to come in a $0.47 versus the consensus of $0.46. Massoud maintained the “outlook that 1Q14 was the low point for...

Alcoa Inc (NYSE: AA) reported its fourth quarter results on Monday after market close. The company earned $0.33 per share, beating the consensus estimate of $0.26 per share while revenue of $6.40 billion topped expectations of $5.99 billion. In a note on Tuesday, Paul Massoud of Stifel...

Monsanto Company (NYSE: MON) will report its first quarter earnings on Wednesday, January 7, before market open. Paul Massoud of Stifel commented on the company's upcoming results in a note to clients on Wednesday. “We believe Monsanto will continue to drive higher seed pricing in 2015 through mix-...

In a report published Thursday, Stifel analyst Paul Massoud reiterated a Buy rating on Alcoa Inc (NYSE: AA), and raised the price target from $17.00 to $20.00. In the report, Stifel noted, “We are raising our 3Q14 EPS estimate from $0.20 to $0.24 (vs. the Street consensus of $0.20), reflecting...

Analysts at Stifel upgraded shares of Monsanto Company (NYSE: MON) to Buy from Hold and established a price target of $135 Thursday. Paul Massoud cited “seasonal trends, favorable valuation, and overdone negative sentiment imply upside for MON shares.” Key points include:...

Earlier Thursday morning, Stifel analyst Paul Massoud downgraded shares of Freeport-McMoran (NYSE: FCX) from Buy to Hold and set a price target of $37. Massoud began by acknowledging that the recent Memorandum of Understanding between Freeport and the Indonesian government is a step in the...

On Thursday morning, Alcoa (NYSE: AA) announced that it will acquire Firth Rixson, a global leader in the production of aerospace jet engine components. Following the announcement, Stifel analyst, Paul Massoud issued a research note which provided some color on the deal. Massoud noted that the $2....

In a report published Friday, Stifel analyst Paul Massoud initiated coverage on The Andersons (NASDAQ: ANDE) at Hold. According to the report, while it is believed that ANDE is entering into a favorable operating environment in 2014, much of the upside is already valued in the stock (up 107.9% in...

In a report published Tuesday, Stifel Nicolaus analyst Paul Massoud initiated coverage on Archer-Daniels-Midland (NYSE: ADM) with a Hold rating. According to the report, “We believe ADM is entering a more favorable operating environment in 2014, though in our opinion, the upside is already...

In a report published Monday, Stifel analyst Paul Massoud reiterated a Buy rating on Marrone Bio Innovations (NASDAQ: MBII), and raised the price target from $17.00 to $19.00. In the report, Stifel noted, “MBI reported 3Q13 revenue of $1.3 million and additional deferred revenues of $770,000 in...

In a report published Tuesday, Stifel analyst Paul Massoud initiated coverage on Marrone Bio Innovations (NASDAQ: MBII) with a Buy rating and $17.00 price target. In the report, Stifel noted, “MBI has developed an efficient sourcing process for microorganisms and plant extracts, an extensive...

In a report published Monday, Stifel Nicolaus analyst Paul Massoud downgraded Agrium (NYSE: AGU) from Buy to Hold, and removed the $99.00 price target. In the report, Stifel Nicolaus noted, “We are lowering our rating on AGU shares from Buy to Hold. In addition to lower potash prices, we...

In a report published Monday, Stifel Nicolaus analyst Paul Massoud reiterated a Buy rating on Freeport-McMoRan Copper & Gold (NYSE: FCX), but lowered the price target from $45.00 to $37.00. In the report, Stifel Nicolaus noted, “We are lowering our target price from $45 to $37 following the...